## Abstract ## Background We reviewed the utility of different treatment modalities in a large series of adolescents/adults with neuroblastoma (NB). ## Procedure The 30 adolescents/adults (median age, 19 years) had stage 2B (nβ=β1), 3 (nβ=β2), or 4 (nβ=β27) NB. Treatments included conventional a
Neuroblastoma in adolescents : The Italian experience
β Scribed by Massimo Conte; Stefano Parodi; Bruno De Bernardi; Claudia Milanaccio; Katia Mazzocco; Paola Angelini; Elisabetta Viscardi; Andrea Di Cataldo; Roberto Luksch; Riccardo Haupt
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 127 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
BACKGROUND: Aggressive fibromatosis (AF) is a rare tumor of intermediate malignancy that has a strong potential for local invasiveness and recurrence. To date, there are no general recommendations for the clinical management of pediatric AF. METHODS: The authors retrospectively analyzed 94 patients
## Abstract ## BACKGROUND Less than 5% of neuroblastomas are diagnosed in adolescent patients. Previous studies of patients who were treated with less intensive chemotherapy regimens relative to currently available regimens suggested that adolescents survived longer than younger children, and this
This chapter explores Italian adolescents' use of free time, highlighting cultural peculiarities, the quality of experience in leisure activities, and implications for individual development.
Eight patients affected by neuroblastoma were treated with 18 courses of 131I-meta-iodobenzylguanidine (MIBG). They all had been judged as "nonresponders" to conventional treatments. Six had stage IV disease: of these, five, with massive marrow involvement, had poor results, mainly because of marrow